GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia

In recognition of securing high-caliber technology in manufacturing plasma derivatives and a track record of overseas plasma fractionation plant construction and technology transfer YONGIN, South Korea, June 1, 2023 /PRNewswire/ — GC Biopharma, a South Korean biopharmaceutical company,…